The Nrf2 pathway as a potential therapeutic target for Huntington disease: A commentary on “Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington disease”

✍ Scribed by Carole Escartin; Emmanuel Brouillet

• Book ID: 113631112
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 119 KB
• Volume: 49
• Category: Article
• ISSN: 0891-5849
• DOI: 10.1016/j.freeradbiomed.2010.04.009